← FDA Drug Approvals (Drugs@FDA)

BROMFENAC SODIUM

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: EUGIA PHARMA · Approved 2022-03-18

Drug application

FDA Application #

ANDA204813

Application type

Abbreviated New Drug Application (Generic)

Brand name

BROMFENAC SODIUM

Generic name

BROMFENAC

Active ingredients

BROMFENAC SODIUM

Dosage form

SOLUTION/DROPS

Route

OPHTHALMIC

Marketing status

Prescription

Sponsor

EUGIA PHARMA

Manufacturer

Aurobindo Pharma Limited

First approval

2022-03-18

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown